Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior.
Bhargava
H N
HN
Department of Pharmaceutics and Pharmacodynamics, College of Pharmacy, University of Illinois at Chicago 60612.
D000595:Amino Acid Sequence; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D004361:Drug Tolerance; D006801:Humans; D007107:Immune System / Q000187:drug effects; D008969:Molecular Sequence Data; D009292:Narcotic Antagonists; D009294:Narcotics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000627:therapeutic use; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000819:agonists*; D015290:Second Messenger Systems / Q000187:drug effects; D012646:Self Administration / Q000009:adverse effects; D013329:Structure-Activity Relationship; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy / Q000209:etiology*; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000209:etiology*
D009292:Narcotic Antagonists; D009294:Narcotics; D018377:Neurotransmitter Agents; D010455:Peptides; D011957:Receptors, Opioid